Namuscla
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Namuscla, covering 2026-01-16 to 2026-06-03. Get the full timeline:
Most recent: EMA Authorised: Namuscla (Mexiletine hydrochloride) — Lupin Europe GmbH